Renal caveolin-1 expression in children with unilateral ureteropelvic junction obstruction

Pediatric Nephrology

Volumn 22, Issue 2, 2007, Pages 237-248

  Vallés, Patricia G ^a,b   Manucha, Walter ^b   Carrizo, Liliana ^a   Perugorria, José Vega ^c   Seltzer, Alicia ^b   Ruete, Celeste ^b  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c Hospital H Notti   (Argentina)

Author keywords

AT1 angiotensin II receptor; Caveolin 1 expression; eNOS mRNA; Obstructive nephropathy; Tubulointerstitial fibrosis

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; CAVEOLIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; PENTETATE TECHNETIUM TC 99M;

ARTICLE; BASOLATERAL MEMBRANE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; INFANT; KIDNEY BIOPSY; KIDNEY CARCINOMA; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY SCINTISCANNING; KIDNEY TUBULE EPITHELIUM; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RISK FACTOR; TISSUE DISTRIBUTION; URETEROPELVIC JUNCTION OBSTRUCTION; URINALYSIS;

APOPTOSIS; BIOPSY; CASE-CONTROL STUDIES; CAVEOLIN 1; CHILD; CHILD, PRESCHOOL; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INFANT; KIDNEY CORTEX; MALE; NITRIC OXIDE SYNTHASE TYPE III; PELVIS; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA, MESSENGER; URETERAL OBSTRUCTION;

EID: 33845697552     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-006-0290-4     Document Type: Article

References (44)

1. Warady BA (1997) Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 annual report of the North American pediatric renal transplantation cooperative study. Pediatr Nephrol 11:49-64
2. Chevalier RL (1998) Effects of ureteral obstruction on renal growth. Semin Nephrol 15:353-360
3. Klahr S (1998) Obstructive nephropathy. Kidney Int 54:286-300
4. Klahr S, Morrissey J (1998) Angiotensin II and gene expression in the kidney. Am J Kidney Dis 31:171-176
5. Pueyo ME, Arnal JF, Rami J, Michel JB (1998) Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells. Am J Physiol 274(Cell Physiol 43):C214-C220
6. Ricardo SO, Diamond JD (1998) The role of macrophages and reactive oxygen species in experimental hydronephrosis. Semin Nephrol 18:612-621
7. Miyajina A, Chen J, Kirman I, Poppas DP, Darracott Vaughan E Jr, Felsen D (2000) Interaction of nitric oxide and transforming growth factor-[beta] induced by angiotensin II and mechanical stretch in rat renal tubular epithelial cells. J Urol 164:1729-1734
8. Vallés P, Pascual L, Manucha W, Carrizo L, Rüttler M (2003) Role of endogenous nitric oxide in unilateral ureteropelvic junction(UPJ) obstruction in children. Kidney Int 63:1104-1111
9. Huang A, Palmer LS, Hom D, Vaderrama E, Trachtman H (2000) The role of nitric oxide in obstructive nephropathy. J Urol 163:1276-1281
10. Thomas SE, Anderson S, Gordon KL (1998) Tubulointerstitial disease in aging: Evidence for underlying peritubular capillary damage, a potential role for renal ischemia. J Am Soc Nephrol 9:231-242
11. Ishizaka N, Griendling KK, Lassegue B, Alexander RW (1998) Angiotensin II type 1 receptor: Relationship with caveolae and caveolin after initial agonist stimulation. Hypertension 32:459-466
12. Li D, Tomson K, Yang B, Mehta P, Croker BP, Mehta JL (1999) Modulation of constitutive nitric oxide synthase, bcl-2 and Fas expression in cultured human coronary endothelial cell exposed to anoxia-reoxygenation and angiotensin II: Role of AT1 receptor activation. Cardiovasc Res 41:109-115
13. Rothberg KG, Heuser JE, Donzell WC, Ying Y, Glenney JR, Anderson RGW (1992) Caveolin, a protein component of caveolae membrane coats. Cell 68:673-682
14. Fra AM, Williamson E, Simons K, Parton RG (1995) De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc Natl Acad Sci USA 92:8655-8659
15. Zhao YY, Liu Y, Stan RV, Fan L, Gu Y, Dalton N, Chu PH, Peterson K, Ross J Jr, Chien KR (2002) Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proc Natl Acad Sci USA 99:11375-11380
16. Cohen AW (2004) Role of caveolae and caveolins in health and disease. Physiol Rev 84:1341-1379
17. Okamoto T, Schlegel A, Scherer PE, Lisanti MP (1998) Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem 273:5419-5422
18. Goligorsky MS, Li H, Brodsky H, Chen J (2002) Relationships between caveolae and eNOS: Everything in proximity and the proximity of everything. Am J Physiol Renal Physiol 283:F1-F10
19. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, Kurzchalia TV (2001) Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293:2449-2452
20. Chun M, Liyanage UK, Lisanti MP, Lodish HF (1994) Signal transduction of a G protein-coupled receptor in caveolae: Colocalization of endothelin and its receptor with caveolin. Proc Natl Acad Sci USA 91:11728-11732
21. Liu P, Ying Y, Ko Y, Anderson RGW (1996) Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae. J Biol Chem 271:10299-10303
22. Mineo C, James GL, Smart EJ, Anderson RGW (1996) Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane. J Biol Chem 271:11930-11935
23. Wyse BD, Prior IA, Qian H, Morrow IC, Nixon S, Muncke C, Kurzchalia TV, Thomas WG, Parton RG, Hancock JF (2003) Caveolin interacts with the angiotensin II type 1 receptor during exocytic transport but not at the plasma membrane. J Biol Chem 278:23738-23746
24. Li S, Couet J, Lisanti MP (1996) Src tyrosine kinases, G alpha subunits and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem 271:29182-29190
25. Peterson Ma E, Guicciardi R, Gulati LS, Kleppe CS, Mueske M, Mookadam G, Sowa GJ, Gores WC, Sessa RD, Simari RD (2003) Caveolin-1 can regulate vascular smooth muscle cell fate by switching platelet-derived growth. Arterioscler Thromb Vasc Biol 23:1521-1527
26. Maizels M, Reisman ME, Nelson J, Fernbach S, Firlit CF, Conway JJ (1992) Grading nephroureteral dilatation detected in the first year of life. Correlation with obstruction. J Urol Part 2 148:609-614
27. Majd M (1992) Nuclear medicine in pediatric urology. In: Kelalis P, King LR, Belman AB (eds) Clinical pediatric urology, Chapt 4, 3rd edn. W.B. Saunders Co, Philadelphia, pp 117-165
28. Chung S, Majd M, Gil Rushton H, Belman B (1993) Diuretic renography in the evaluation of neonatal hydronephrosis: Is it reliable? J Urol 150:765-768
29. (1987) Report of the Second Task Force on blood pressure control in children - 1987. Task Force on blood pressure control in children. National Heart, Lung, and Blood Institute, Bethesda, Maryland. Pediatrics 79:1-25
30. Schwartz GJ, Haycock GB, Spitzer A (1976) Plasma creatinine and urea concentration in children. J Pediatr 88:828-832
31. Hruska KA, Guo G, Wozniak M, Martin D, Miller S, Liapis H, Loveday K, Klahr S, Sampath TK, Morrissey J (2000) Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Renal Physiol 279:F130-F143
32. Morrissey J, Hruska K, Guo G, Wang S, Chen Q, Klahr S (2002) Bone morphometric protein-7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 13:S14-S21
33. William T, Lisanti M (2004) The Caveolin genes: From cell biology to medicine. Ann Med 36:584-595
34. Pimentel JL, Martinez Maldonado M, Wilcox JN, Wang S, Luo C (1993) Regulation of renin-angiotensin system in unilateral ureteral obstruction. Kidney Int 44:390-400
35. Klahr S, Morrissey J (1998) The role of growth factors, cytokines, and vasoactive compounds in obstructive nephropathy. Semin Nephrol 18:622-632
36. Mahmoudi M, Willgoss D, Cuttle L, Yang T, Pat B, Winterford C, Endre Z, Johnson DW, Gobe GC (2003) In vivo and in vitro models demonstrate a role for caveolin-1 in the pathogenesis of ischaemic acute renal failure. J Pathol 200:396-404
37. Zager RA, Johnson A, Hanson S, De La Rosa V (2002) Altered colesterol localization and caveolin expression during the evolution of acute renal failure. Kidney Int 61:1674-1683
38. Cachat F, Lange-Sperandio B, Chang AY, Kiley S, Thornhill BA, Forbes M, Chevalier RL (2003) Ureteral obstruction in neonatal mice elicits segment-specific tubular cell responses leading to nephron loss. Kidney Int 63:564-575
39. Truong LD, Sheikh-Hamad D, Chakaborty S, Suki WN (1998) Cell apoptosis and proliferation in obstructive uropathy. Semin Nephrol 18:641-651
40. Gobe GC, Axelsen RA (1987) Genesis of renal tubular atrophy in experimental hydronephrosis in the rat. Lab Invest 56:273-281
41. Schumer M, Colombel MC, Sawczuk IS, Gobe G, Connor J, O'Toole KM, Olsson CA, Wise GJ, Buttyan R (1992) Morphologic, biochemical and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 140:831-838
42. 2+-calmodulin and caveolin. J Biol Chem 272:15583-15586
43. Sindhu RK, Ehdaie A, Vaziri ND, Ohashi R, Shimizu A, Masuda Y, Kitamura H, Ishizaki M, Sugisaki Y, Yamanaka N (2002) Peritubular capillary regression during the progression of experimental obstructive nephropathy. J Am Soc Nephrol 13:1795-1805
44. Roberts CK (2004) Effects of chronic renal failure on caveolin-1, guanylate cyclase and AKT protein expression. Biochim Biophys Acta 1690:231-237